Recombinant multi-species Inhibin alpha/INHA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Inhibin alpha/INHA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the TGF-beta (transforming growth factor-beta) superfamily of proteins. The encoded preproprotein is proteolytically processed to generate multiple peptide products, including the alpha subunit of the inhibin A and B protein complexes. These complexes negatively regulate follicle stimulating hormone secretion from the pituitary gland. Inhibins have also been implicated in regulating numerous cellular processes including cell proliferation, apoptosis, immune response and hormone secretion. Mutations in this gene may be associated with male infertility and premature ovarian failure in female human patients. [provided by RefSeq, Aug 2016]
The Alternative Names of target: INHA,Inha,Inhibin alpha,Inhibin alpha chain

Target products collectionGo to Inhibin alpha/INHA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1032-Ag-1/ GM-Tg-hg-SE1032-Ag-2 Human Inhibin alpha/INHA protein Human
GM-Tg-rg-SE1032-Ag-1/ GM-Tg-rg-SE1032-Ag-2 Rat Inhibin alpha/INHA protein Rat
GM-Tg-mg-SE1032-Ag-1/ GM-Tg-mg-SE1032-Ag-2 Mouse Inhibin alpha/INHA protein Mouse
GM-Tg-cynog-SE1032-Ag-1/ GM-Tg-cynog-SE1032-Ag-2 Cynomolgus/Rhesus macaque Inhibin alpha/INHA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1032-Ag-1/ GM-Tg-felg-SE1032-Ag-2 Feline Inhibin alpha/INHA protein Feline
GM-Tg-cang-SE1032-Ag-1/ GM-Tg-cang-SE1032-Ag-2 Canine Inhibin alpha/INHA protein Canine
GM-Tg-bovg-SE1032-Ag-1/ GM-Tg-bovg-SE1032-Ag-2 Bovine Inhibin alpha/INHA protein Bovine
GM-Tg-equg-SE1032-Ag-1/ GM-Tg-equg-SE1032-Ag-2 Equine Inhibin alpha/INHA protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1032-Ag-1/ GM-Tg-hg-SE1032-Ag-2; GM-Tg-rg-SE1032-Ag-1/ GM-Tg-rg-SE1032-Ag-2;
GM-Tg-mg-SE1032-Ag-1/ GM-Tg-mg-SE1032-Ag-2; GM-Tg-cynog-SE1032-Ag-1/ GM-Tg-cynog-SE1032-Ag-2;
GM-Tg-felg-SE1032-Ag-1/ GM-Tg-felg-SE1032-Ag-2; GM-Tg-cang-SE1032-Ag-1/ GM-Tg-cang-SE1032-Ag-2;
GM-Tg-bovg-SE1032-Ag-1/ GM-Tg-bovg-SE1032-Ag-2; GM-Tg-equg-SE1032-Ag-1/ GM-Tg-equg-SE1032-Ag-2
Products Name Inhibin alpha/INHA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Inhibin alpha/INHA
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Inhibin alpha/INHA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.